Chlorphenesin
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Excretion | urine |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C10H12ClNO4 |
| Molar mass | 245.660 g/mol |
| 3D model (JSmol) | |
| Melting point | 86 to 92 °C |
| |
| |
|
WikiDoc Resources for Chlorphenesin |
|
Articles |
|---|
|
Most recent articles on Chlorphenesin Most cited articles on Chlorphenesin |
|
Media |
|
Powerpoint slides on Chlorphenesin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Chlorphenesin at Clinical Trials.gov Trial results on Chlorphenesin Clinical Trials on Chlorphenesin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Chlorphenesin NICE Guidance on Chlorphenesin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Chlorphenesin Discussion groups on Chlorphenesin Patient Handouts on Chlorphenesin Directions to Hospitals Treating Chlorphenesin Risk calculators and risk factors for Chlorphenesin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Chlorphenesin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Chlorphenesin (Maolate, Musil) is a centrally acting muscle relaxant used to treat muscle pain and spasms.[1][2] Chlorphenesin is no longer used for this purpose in most developed nations due to the availability of much safer spasmolytics such as benzodiazepines.
Other central effects include sedation, anxiolysis, and dizziness. It also has antifungal and some antibacterial properties and is thus classified as an antifungal for topical use by the WHO.[3]
Safety
The major adverse effect from this preservative on skin is allergic contact sensitivity.[4][5] Systemic intoxication from transdermal use has not been observed, although the FDA discourages its use as an ingredient in nipple cream for nursing mothers.[6]
References
- ↑ Okuyama, S; Aihara, H (1987). "Antinociceptive effect of chlorphenesin carbamate in adjuvant arthritic rats". Research communications in chemical pathology and pharmacology. 55 (2): 147–60. PMID 3823606.
- ↑ Kurachi, M; Aihara, H (1984). "Effect of a muscle relaxant, chlorphenesin carbamate, on the spinal neurons of rats". Japanese journal of pharmacology. 36 (1): 7–13. doi:10.1254/jjp.36.7. PMID 6503049.
- ↑ ATC code D01AE07
- ↑ Brown R (1981). "Chlorphenesin sensitivity". Contact Dermatitis. 7 (3): 162. doi:10.1111/j.1600-0536.1981.tb04601.x. PMID 6456118.
- ↑ Burns DA (1986). "Allergic contact sensitivity to chlorphenesin". Contact Dermatitis. 14 (33): 246. doi:10.1111/j.1600-0536.1986.tb01234.x. PMID 2941223.
- ↑ http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116900.htm. Missing or empty
|title=(help)
- Pages with citations lacking titles
- Pages with citations having bare URLs
- Articles with short description
- Template:drugs.com link with non-standard subpage
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Muscle relaxants
- Carbamates
- Alcohols
- Drug
- Phenol ethers
- Organochlorides
